SIGN UPLog In

Last deal

Amount

Venture - Series Unknown

Stage

21.11.2016

Date

4

all rounds

$10.5M

Total amount

General

About Company
UK's Atopix Therapeutics develops oral anti-allergic medicines for atopic dermatitis, asthma, and allergic rhinitis.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2012

Number of employees

1-10

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

The company is currently focused on developing a novel class of medicines called CRTH2 antagonists, which are being studied in a Phase 2 clinical trial for moderate to severe atopic dermatitis. Atopix Therapeutics is privately held and has its headquarters in Oxford, UK.
Contacts

location

Abingdon, UK

Phone number

Website URL

http://atopixtherapeutics.co.uk